In this issue:
Diabetes
Glargine vs. sitagliptin in metformin-uncontrolled type 2 diabetes
Exenatide vs. glimepiride in type 2 diabetes with metformin failure
Clinical relevance of anti-exenatide antibodies
A year of structured education in flexible insulin therapy
Please login below to download this issue (PDF)